Literature DB >> 25512187

Relationship between serum uric acid and electrocardiographic alterations in a large sample of general population: data from the Brisighella Heart Study.

Arrigo F G Cicero1, Martina Rosticci, Alessandra Reggi, Giuseppe Derosa, Angelo Parini, Elisa Grandi, Sergio D'Addato, Claudio Borghi.   

Abstract

INTRODUCTION: Serum uric acid (SUA) may contribute to the increased cardiovascular damage through direct injury to the endothelium and alteration of cardiovascular function. AIM: To evaluate the association of SUA with the presence of the most recurrent electrographic alterations and with the length of the main ECG intervals in a large sample of general population.
METHODS: For this study, on the database of the Brisighella Heart Study, we evaluated the available data of 790 men and 849 women, excluding subjects affected by gout or taking antihyperuricemic agents, those taking drug increasing the QT interval and those using beta-blockers or non-dihydropyridine calcium channel blockers at the moment of the ECG registration. Multiple ascending stepwise regression analyses were carried out to determine the independent predictors of the predefined ECG alterations.
RESULTS: The prevalence of predefined ECG alterations was comparable between genders, with the exception of sinus bradicardia, left-anterior fascicular block, atrio-ventricular blocks and left ventricular hypertrophy (LVH), which appeared to be more frequent in men. The multivariate analysis revealed that SUA was associated to ischaemic alterations, LVH, sinus tachycardia and tachyarrhytmias. Age was associated to all evaluated ECG alterations beyond sinus tachycardia and LVH. Male sex was associated to sinus bradicardia, atrio-ventricular blocks, anterior-left fascicular block and LVH. Blood pressure was associated to different ECG alterations, but with clinically relevant OR with ischaemic alterations and LVH.
CONCLUSION: SUA level is related the prevalence of both organic and rhythm ECG alterations in a wide sample of general population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25512187     DOI: 10.1007/s40292-014-0077-9

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  31 in total

1.  Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women--the Tromso Study.

Authors:  Audhild Nyrnes; Ingrid Toft; Inger Njølstad; Ellisiv B Mathiesen; Tom Wilsgaard; John-Bjarne Hansen; Maja-Lisa Løchen
Journal:  Europace       Date:  2013-08-30       Impact factor: 5.214

2.  Hyperuricemia attenuates aortic nitric oxide generation, through inhibition of arginine transport, in rats.

Authors:  Idit F Schwartz; Ayelet Grupper; Tamara Chernichovski; Avishai Grupper; Oren Hillel; Anat Engel; Doron Schwartz
Journal:  J Vasc Res       Date:  2010-11-23       Impact factor: 1.934

3.  Dietary determinants of oxidized-low-density lipoprotein antibodies in a sample of pharmacologically untreated non-smoker subjects: data from the Brisighella heart study.

Authors:  Arrigo F G Cicero; Alessandra Reggi; Elisa Tartagni; Elisa Grandi; Sergio D'Addato; Claudio Borghi
Journal:  Adv Clin Exp Med       Date:  2013 Jan-Feb       Impact factor: 1.727

Review 4.  Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

Authors:  Seo Young Kim; James P Guevara; Kyoung Mi Kim; Hyon K Choi; Daniel F Heitjan; Daniel A Albert
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

Review 5.  Hyperuricemia and incident hypertension: a systematic review and meta-analysis.

Authors:  Peter C Grayson; Seo Young Kim; Michael LaValley; Hyon K Choi
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-01       Impact factor: 4.794

6.  Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells.

Authors:  Sergey Zharikov; Karina Krotova; Hanbo Hu; Chris Baylis; Richard J Johnson; Edward R Block; Jawaharlal Patel
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-10       Impact factor: 4.249

7.  Association of serum uric acid and cardiovascular disease in healthy adults.

Authors:  Shaye Kivity; Eran Kopel; Elad Maor; Fadi Abu-Bachar; Shlomo Segev; Yechezkel Sidi; David Olchovsky
Journal:  Am J Cardiol       Date:  2013-01-24       Impact factor: 2.778

8.  The association between hyperuricemia, left atrial size and new-onset atrial fibrillation.

Authors:  Tze-Fan Chao; Chung-Lieh Hung; Su-Jung Chen; Kang-Ling Wang; Tzeng-Ji Chen; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Shih-Ann Chen
Journal:  Int J Cardiol       Date:  2013-07-17       Impact factor: 4.164

9.  Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure?

Authors:  Xu Duan; Feng Ling
Journal:  Med Hypotheses       Date:  2007-08-06       Impact factor: 1.538

10.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

View more
  7 in total

Review 1.  Conventional and new electrocardiographic criteria for hypertension-mediated cardiac organ damage: A narrative review.

Authors:  Francesca Miceli; Vivianne Presta; Barbara Citoni; Flaminia Canichella; Ilaria Figliuzzi; Andrea Ferrucci; Massimo Volpe; Giuliano Tocci
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-06       Impact factor: 3.738

2.  Electrocardiogram Derived QRS Duration >120 ms is Associated With Elevated Plasma Homocysteine Levels in a Rural Australian Cross-Sectional Population.

Authors:  Yvonne Lee Yin Leng; Yuling Zhou; Honghong Ke; Herbert Jelinek; Joel McCabe; Hassan Assareh; Craig S McLachlan
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

3.  Middle and Long-Term Impact of a Very Low-Carbohydrate Ketogenic Diet on Cardiometabolic Factors: A Multi-Center, Cross-Sectional, Clinical Study.

Authors:  Arrigo F G Cicero; Maddalena Benelli; Marco Brancaleoni; Giuseppe Dainelli; Desiré Merlini; Raffaele Negri
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-05-19

4.  Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product.

Authors:  Arrigo Francesco Giuseppe Cicero; Federica Fogacci; Martino Morbini; Alessandro Colletti; Marilisa Bove; Maddalena Veronesi; Marina Giovannini; Claudio Borghi
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-05-23

5.  Laboratory and Instrumental Risk Factors Associated with a Sudden Cardiac Death Prone ECG Pattern in the General Population: Data from the Brisighella Heart Study.

Authors:  Pierangelo Coppola; Arrigo Francesco Giusepp Cicero; Federica Fogacci; Sergio D'Addato; Stefano Bacchelli; Claudio Borghi
Journal:  J Clin Med       Date:  2021-02-08       Impact factor: 4.241

6.  Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial.

Authors:  Arrigo Francesco Giuseppe Cicero; Alessandro Colletti; Federica Fogacci; Marilisa Bove; Martina Rosticci; Claudio Borghi
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-06-23

7.  Increased Overall Heart Rate Irregularity Risk by Hyperuricemia in the General Population: Results from the Korean National Health and Nutrition Examination Survey.

Authors:  Yeonghee Eun; Kyung-Do Han; Da Hye Kim; In Young Kim; Eun-Jung Park; Seulkee Lee; Hoon-Suk Cha; Eun-Mi Koh; Jaejoon Lee; Hyungjin Kim
Journal:  Medicina (Kaunas)       Date:  2020-09-24       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.